Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer

[1]  W. Tan,et al.  Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer , 2010, Journal of Medical Genetics.

[2]  D. Compton,et al.  Mechanisms of Chromosomal Instability , 2010, Current Biology.

[3]  D. Baker,et al.  Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. , 2009, Cancer cell.

[4]  A. Irmisch,et al.  Smc5-Smc6-Dependent Removal of Cohesin from Mitotic Chromosomes , 2009, Molecular and Cellular Biology.

[5]  J. Cerhan,et al.  Genetic Variation in the Chromosome 17q23 Amplicon and Breast Cancer Risk , 2009, Cancer Epidemiology Biomarkers & Prevention.

[6]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[7]  M. Gazouli,et al.  Survivin -31G/C promoter polymorphism and sporadic colorectal cancer , 2009, International Journal of Colorectal Disease.

[8]  David O. Morgan,et al.  Positive feedback sharpens the anaphase switch , 2008, Nature.

[9]  C. Sotiriou,et al.  Understanding the Molecular Basis of Histologic Grade , 2008, Pathobiology.

[10]  C. H. Kim,et al.  Polymorphisms in the survivin gene and the risk of lung cancer. , 2008, Lung cancer.

[11]  J. Gu,et al.  STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study. , 2007, Gynecologic oncology.

[12]  David Pellman,et al.  Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells , 2005, Nature.

[13]  A. Balmain,et al.  Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. , 2005, Carcinogenesis.

[14]  Yup Kang,et al.  Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships , 2005, Breast Cancer Research.

[15]  E. Bleecker,et al.  Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk. , 2002, Cancer genetics and cytogenetics.

[16]  M. Molinari.  Cell cycle checkpoints and their inactivation in human cancer , 2000, Cell proliferation.

[17]  D. Visscher,et al.  Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[18]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[19]  J. Cerhan,et al.  Centrosome-related genes, genetic variation, and risk of breast cancer , 2010, Breast Cancer Research and Treatment.

[20]  J. Cerhan,et al.  Variation in genes required for normal mitosis and risk of breast cancer , 2009, Breast Cancer Research and Treatment.

[21]  V. Shane Pankratz,et al.  Association of genetic variation in mitotic kinases with breast cancer risk , 2009, Breast Cancer Research and Treatment.

[22]  S. Lowe,et al.  Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. , 2007, Cancer cell.